Back to LGND Stock Lookup

Ligand Pharma (LGND) –

Jul 19, 2016 04:46 PM Form CT ORDER LIGAND PHARMACEUTICALS
Jul 19, 2016 10:21 AM Roth Capital Affirms Ligand Pharma (LGND) Following Solid Q2 Revenue Results for Promacta (NVS)
Jul 14, 2016 09:00 AM Ligand to Report Second Quarter Results on August 4th
Jul 12, 2016 08:37 AM Roth Affirms Ligand Pharma (LGND) at 'Buy' Following Strong Severe PPD Data from SAGE Therapeutics (SAGE)
Jul 8, 2016 02:49 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BlackRock Inc.
Jul 8, 2016 09:47 AM Roth Positive on Ligand Pharma (LGND) Amid Another Key OmniAb Collaboration (GILD)
Jul 8, 2016 09:02 AM Ligand Pharma (LGND) Enters OmniAb Licensing Agreement with Gilead (GILD)
Jul 8, 2016 09:00 AM Ligand Enters into OmniAb® Platform License Agreement with Gilead Sciences
Jul 5, 2016 07:59 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: Korenberg Matthew E
Jul 5, 2016 07:57 PM Form 4 LIGAND PHARMACEUTICALS For: Jul 01 Filed by: KOZARICH JOHN W
Jul 5, 2016 07:57 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: Herman Melanie J
Jul 5, 2016 09:18 AM Roth Keeps Ligand Pharma (LGND) at 'Buy' as Kyprolis Receives Expanded Indication in Europe (AMGN)
Jun 30, 2016 04:05 PM Ligand Pharma (LGND) Receives $4M from Expansion of Two OmniAb License Agreements
Jun 30, 2016 04:02 PM Ligand Receives $4 Million from Expansion of Two OmniAb® License Agreements
Jun 9, 2016 01:55 PM Form CT ORDER LIGAND PHARMACEUTICALS
Jun 7, 2016 02:39 PM Form CT ORDER LIGAND PHARMACEUTICALS
Jun 7, 2016 02:30 PM Form CT ORDER LIGAND PHARMACEUTICALS
Jun 3, 2016 04:42 PM Form 4 LIGAND PHARMACEUTICALS For: May 20 Filed by: KOZARICH JOHN W
May 25, 2016 07:57 PM Form 4 LIGAND PHARMACEUTICALS For: May 23 Filed by: Sabba Stephen L
May 25, 2016 07:19 PM Form 4 LIGAND PHARMACEUTICALS For: May 23 Filed by: Patel Sunil
May 25, 2016 07:18 PM Form 4 LIGAND PHARMACEUTICALS For: May 23 Filed by: LAMATTINA JOHN L
May 25, 2016 07:16 PM Form 4 LIGAND PHARMACEUTICALS For: May 23 Filed by: KOZARICH JOHN W
May 25, 2016 07:15 PM Form 4 LIGAND PHARMACEUTICALS For: May 23 Filed by: Aryeh Jason
May 25, 2016 07:15 PM Form 4 LIGAND PHARMACEUTICALS For: May 23 Filed by: Davis Todd C
May 25, 2016 04:01 PM Form 8-K LIGAND PHARMACEUTICALS For: May 23
May 24, 2016 12:59 PM Form SC 13D/A LIGAND PHARMACEUTICALS Filed by: KNOTT DAVID M
May 19, 2016 06:29 PM Form 4 LIGAND PHARMACEUTICALS For: May 18 Filed by: Herman Melanie J
May 16, 2016 08:30 AM Intec Pharma to Nominate Dr. John W. Kozarich as Chairman of the Board of Directors
May 12, 2016 12:22 PM Streetinsider.com's Hot Lunchtime Reads 5/12: (AAPL) (BA) (LVLT) (JCP)
May 12, 2016 12:01 PM Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' as Baxdela Phase 3 Met Primary Endpoints
May 9, 2016 08:33 AM Form 10-Q LIGAND PHARMACEUTICALS For: Mar 31
May 9, 2016 08:16 AM Form 8-K/A LIGAND PHARMACEUTICALS For: May 03
May 9, 2016 08:00 AM Form 4 LIGAND PHARMACEUTICALS For: May 05 Filed by: Aryeh Jason
May 4, 2016 08:16 AM Ligand Pharma (LGND) Tops Q1 EPS by 30c
May 4, 2016 06:17 AM Form 8-K LIGAND PHARMACEUTICALS For: May 04
May 4, 2016 06:08 AM Ligand Pharma (LGND) Acquires Economic Rights to CorMatrix Product Offerigs
May 4, 2016 06:00 AM Ligand Reports First Quarter 2016 Financial Results
May 4, 2016 05:59 AM Ligand Acquires Portfolio of Synthetic Royalty and Milestone Rights from CorMatrix® Cardiovascular for $17.5 Million
May 3, 2016 05:34 PM Form 4 LIGAND PHARMACEUTICALS For: May 02 Filed by: KOZARICH JOHN W
May 3, 2016 02:28 PM Trading Radar for 5/4: Tesla (TSLA), Time Warner (TWX), Priceline Group (PCLN), Fitbit (FIT), MetLife (MET) Report
Apr 22, 2016 02:23 PM Roth Affirms Ligand Pharma (LGND) at 'Buy' Following FDA Acceptance of Lundbeck's CE-Carbamazepine NDA Resubmission
Apr 22, 2016 09:00 AM Ligand Announces First Quarter 2016 Earnings Reporting Date and Participation in Four Upcoming Investor Conferences
Apr 20, 2016 12:37 PM Orphan Drug Exclusivity for Spectrum's (SPPI) Evomela is Important Increment for Ligand (LGND) - Roth Capital
Apr 20, 2016 07:01 AM Spectrum Pharma's (SPPI) EVOMELA Granted Orphan Drug Exclusivity by U.S. FDA
Apr 20, 2016 07:00 AM FDA Grants Orphan Drug Exclusivity to EVOMELA™ (melphalan) for Injection, Indicated for Multiple Myeloma
Apr 18, 2016 01:50 PM Form CT ORDER LIGAND PHARMACEUTICALS
Apr 14, 2016 06:46 AM Viking Therapeutics (VKTX) Issues Ligand Pharmaceutical (LGND) 960K Shares and Warrants Related to Loan Agreement
Apr 13, 2016 08:38 AM Stephens Starts Ligand Pharma (LGND) at Overweight
Apr 12, 2016 04:06 PM Form DEFA14A LIGAND PHARMACEUTICALS
Apr 12, 2016 04:04 PM Form DEF 14A LIGAND PHARMACEUTICALS For: Apr 12

Back to LGND Stock Lookup